Skip to content

Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03544619
Enrollment
120
Registered
2018-06-04
Start date
2018-06-10
Completion date
2020-12-30
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain

Brief summary

In this study, investigators want to perform the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Detailed description

The purpose of the study is to determine the Turkish version, the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory. 120 patients with neuropathic pain will be included in the study. Test-retest and internal consistency analysis were conducted to determine the reliability of the questionnaire. Test-retest results evaluated using the Intraclass Correlation Coefficient method.

Interventions

Investigators will use the Neuropathic Pain Symptom Inventory for assessing neuropathic symptoms

Sponsors

Erenköy Physical Therapy and Rehabilitation Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age upper 18 * Complaints of neuropathic pain for at least 3 months

Exclusion criteria

* Presence of psychiatric illness * Cancer pain, unsuccessful lumbar surgeon syndrome etc. mix type pain presence * Presence of complex regional pain syndrome * Cognitive impairment (mini-mental test score \<24) * Native language is not Turkish

Design outcomes

Primary

MeasureTime frameDescription
Reliability and adaptation7 weeksInvestigators will use linguistic validaiton guideline of Mapi research.
DN45 minutesDN4 has become one of the principal condition-specific outcome measures of neuropathic pain.Investigators will use it for comparing results of NPSI.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026